Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of …
L Creaney, A Wallace, M Curtis… - British journal of sports …, 2011 - bjsm.bmj.com
Background Growth factor technologies are increasingly used to enhance healing in
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of …
L Creaney, A Wallace, M Curtis… - British Journal of Sports …, 2011 - europepmc.org
Background Growth factor technologies are increasingly used to enhance healing in
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
[PDF][PDF] Growth Factor-based Therapies Provide Additional Benefit Beyond Physical Therapy in Resistant Elbow Tendinopathy
L Creaney, A Wallace, M Curtis, D Connell - scholar.archive.org
Background Growth factor technologies are increasingly used to enhance healing in
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
[PDF][PDF] Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial …
L Creaney, A Wallace, M Curtis, D Connell - 2011 - researchgate.net
Background Growth factor technologies are increasingly used to enhance healing in
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of …
L Creaney, A Wallace, M Curtis… - British Journal of Sports …, 2011 - bjsm.bmj.com
Background Growth factor technologies are increasingly used to enhance healing in
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of …
L Creaney, A Wallace, M Curtis, D Connell - 2011 - pubmed.ncbi.nlm.nih.gov
Background Growth factor technologies are increasingly used to enhance healing in
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: A prospective, single-blind, randomised trial of …
L Creaney, A Wallace, M Curtis… - British Journal of Sports …, 2011 - research.monash.edu
Background: Growth factor technologies are increasingly used to enhance healing in
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of …
L Creaney, A Wallace, M Curtis… - British Journal of Sports …, 2011 - search.proquest.com
Background Growth factor technologies are increasingly used to enhance healing in
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …
musculoskeletal injuries, particularly in sports medicine. Two such products; platelet-rich …